Companies /Healthcare

APMD

APMD Biotechnology
$21.09
▼ $0.54 (−2.50%) today
Markets closed · 3:40am ET

Fundamentals

Market Cap
$900.5M
P/E Ratio
3.9
Profit Margin
142.1%
Revenue (TTM)
$115.1M
EPS (TTM)
$5.49
52-Week Range
$16 – $35
Street Target
$50.33

About APMD

Apnimed, Inc. is a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. The company is headquartered in Cambridge, Massachusetts.

APMD Coverage